The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and GenesVolume I : Neuropsychological Endophenotypes and Biomarkers

DESCRIZIONE

Neuropsychiatric disorders such as schizophrenia, mood disorders, Alzheimer's disease, epilepsy, alcoholism, substance abuse and others are some of the most debilitating illnesses worldwide characterizing by the complexity of the causes, and lacking the laboratory tests that may promote diagnostic and prognostic procedures. Recent advances in neuroscience, genomic, genetic, proteomic and metabolomic knowledge and technologies have opened the way to searching biomarkers and endophenotypes, which may offer powerful and exciting opportunity to understand the etiology and the underlying pathophysiological mechanisms of neuropsychiatric disorders. The challenge now is to translate these advances into meaningful diagnostic and therapeutic advances.Table of contents ForewordContributorsPart I. Methodological and Technological Advances1. Where do we stand in the quest for neuropsychiatric biomarkers and endophenotypes and what next? Michael S. Ritsner and Irving I. Gottesman2. Methodological and statistical issues in the use of biomarkers in clinical and research studies. Ryan Van Lieshout and Peter Szatmari3. Challenging the genetic complexity of schizophrenia by use of endophenotypes. Assen Jablensky4. Translational medicine: functional biomarkers for drug development of "cognitive enhancers" in schizophrenia. Georg Winterer5. Leveraging high-dimensional neuroimaging data in genetic studies of neuropsychiatric disease. Cinnamon S. Bloss, Trygve E. Bakken, Alexander H. Joyner, Nicholas J. Schork6. Proteomics as a new tool for biomarker-discovery in neuropsychiatric disorders. Thomas J. Raedler, Harald Mischak, Holger Jahn, Klaus Wiedemann7. Schizophrenia endophenotypes as treatment targets. Stephen I. Deutsch, Barbara L. Schwartz, Richard B. Rosse, John Mastropaolo, Ayman H. Fanous, Abraham Weizman, Jessica A. Burket, Brooke L. GaskinsPart II. Neuropsychological, Neurocognitive and Neurophysiological Domains8. Neuropsychological endophenotypes in schizophrenia and bipolar I disorder: yields from the Finnish family and twin studies. Annamari Tuulio-Henriksson, Jonna Perälä, Irving I. Gottesman and Jaana Suvisaari9. Is more cognitive experimental psychopathology of schizophrenia really necessary? Challenges and opportunities. Angus MacDonald, III10. Intellectual functioning as an endophenotype for schizophrenia. Odette de Wilde11. Emotion recognition deficits as a neurocognitive marker of schizophrenia liability. Renata Schoeman, Dana J. H. Niehaus, Liezl Koen, Jukka M. Leppänen12. The use of neurocognitive endophenotypes in large-scale family genetic studies of schizophrenia. William P. Horan, Tiffany A. Greenwood, David L. Braff, Raquel E. Gur and Michael F. Green13. Neurocognitive endophenotypes for bipolar disorder: evidence from case-control, family and twin studies. Eugenia Kravariti, Fergus Kane, Robin Murray14. Trait and state markers of schizophrenia in visual processing. Yue Chen, Daniel Norton and Ryan McBain15. Visual scanning abnormalities as biomarker for schizophrenia and bipolar disorder. Patricia E. G. Bestelmeyer16. Biomarkers and endophenotypes in eating disorders. Carolina Lopez, Marion Roberts and Janet Treasure17. Movement abnormalities: a putative biomarker of risk for psychosis. Vijay Mittal and Elaine WalkerAfterword by Robert H. BelmakerContents of Volumes 2, 3, and 4Contributors of Volumes 2, 3, and 4Index

DETTAGLI PRODOTTO  torna su

ISBN: 9781402094637

Titolo: The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and GenesVolume I : Neuropsychological Endophenotypes and Biomarkers

Autori: Ritsner

Editore: Springer Verlag

Volume: Primo

Edizione: 2009

Lingua: Inglese

Finitura: Copertina rigida

RECENSIONI

NESSUNA RECENSIONE PER QUESTO PRODOTTO